Dr. Sean Dev Machanda, MD

Dr. Machanda practices at University of Toledo Medical Center in Toledo, Ohio, part of The University of Toledo Medical Center.

Dr. Machanda's NPI, 1538125760, was assigned on April 25, 2006. Dr. Machanda holds Ohio license 35084299.

Dr. Machanda's primary practice is University of Toledo Medical Center, at 3000 Arlington Avenue, Toledo, OH 43614 in Lucas County. The practice phone is (419) 383-3407.

Dr. Machanda's primary practice is University of Toledo Medical Center in Toledo, Ohio, part of The University of Toledo Medical Center. Dr. Machanda is also affiliated with ProMedica Toledo Hospital. The medical group on file is UT Physicians Group. Dmand AI also links Dr. Machanda to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Machanda practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Machanda's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Machanda is licensed in Ohio.

CMS data shows 495 Medicare services from Dr. Machanda across 10 procedure codes in 2024, for 184 Medicare patients. Medicare paid $43,864 for them. Every service was in an office.

CMS counts 184 Medicare patients who saw Dr. Machanda in 2024. The largest group is 65 to 74, with 99 patients. 69% of them have high blood pressure, and 59% have high cholesterol. 10% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Machanda's median patient age at 68, with 43% women.

In 2024, Dr. Machanda wrote 11,468 Medicare Part D claims for 611 patients. 87% of them were for generic drugs. CMS names the drug for 10,613 of them, across 165 drugs with 11 or more claims each, at $727,608 in total drug cost. In 2023, CMS named 10,287 claims across 178 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Machanda for performance year 2024, reported as part of a group. Dr. Machanda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Machanda from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 76% of the total. Novo Nordisk Inc paid the most, $19.